Educational research tool. Not investment advice. You are responsible for your own trading decisions.

Verdix.
← All analysis

Uber Technologies, Inc. (UBER)

Verdict history · UBER

Every call Verdix has made on UBER.

While a verdict holds, its return keeps accumulating from the day the call was made — it resets only when the verdict itself changes.

Click any date below to read that write-up

WaitBuy· Aug 22, 2026

The prior WAIT hinged on a single technical condition: reclaim the weekly EMA50 above $77 on volume. That trigger fired cleanly the week of August 17, converting the panel's posture from WAIT to BUY. The valuation case did not need to improve — the price simply crossed the threshold that every bullish voice had designated as the line between a corrective phase and a resumption of the Stage 2 uptrend, while the lone Bearish dissent remained fixed on business quality rather than price.

See methodology for how verdicts are produced. Full track record →

The panel’s case for UBER — and where they disagree.

BuyLOW confidence

The case for outweighs the case against at today's price.

NYSE · Industrials · 2026-08-22 · analysis, not advice

Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.

Verdict

Buy

LOW confidence

Why

A six-analyst panel upgrades Uber to BUY at $78.80 after the stock cleared the technical trigger the prior WAIT demanded, but conviction stays LOW because one Bearish voice flags deteriorating tangible equity and a balance sheet that burned $6.8 billion in cash over six months. The debate centers on whether Uber's $10B+ free cash flow is a durable compounding engine or a headline propped up by non-recurring gains, with the next earnings print and the $76.53 support level as the two data points that will settle the argument.

Level to watch

Key resistance 79.38

+0.7% from 78.8

Next catalyst

Trigger to confirm the breakout: A weekly close above $82.14 (R2, monthly horizontal with Fibonacci confluence) would confirm Stage 2 resumption and elevate panel confidence from LOW to MEDIUM without changing the BUY verdict.

The panel's take

Verdict: BUY · Conviction: LOW · Last price: 78.8 · Changed from WAIT

Panel: 4 Bullish · 1 Neutral · 1 Bearish → BUY

What changed since 2026-08-15:

  • Price: 75.95 → 78.8 (+3.75%)
  • Panel: 4 of 6 → 4 of 6 now Bullish — composition also changed: added The Activist Catalyst; removed The Moat Compounder
  • Trigger: SELL if UBER closes a week below $76.53 (monthly EMA20) — that breaks the Stage 2 structure every bullish voice cited as their invalidation point and would signal this bounce was a trap. On the upside, a weekly close above $82.14 (R2, monthly horizontal + Fibonacci confluence) would elevate confidence from LOW to MEDIUM by confirming Stage 2 resumption, but the verdict would not flip — it is already a BUY.
  • Verdict: WAIT → BUY

The prior WAIT hinged on a single technical condition: reclaim the weekly EMA50 above $77 on volume. That trigger fired cleanly the week of August 17, converting the panel's posture from WAIT to BUY. The valuation case did not need to improve — the price simply crossed the threshold that every bullish voice had designated as the line between a corrective phase and a resumption of the Stage 2 uptrend, while the lone Bearish dissent remained fixed on business quality rather than price.

The prior WAIT trigger fired cleanly — UBER closed the week of 2026-08-17 at $78.80, above $77, on 0.91x 50-week average volume, confirming the EMA50 reclaim the panel had demanded. That trigger converts the WAIT to a BUY. Four of six voices are outright bullish: the fundamental scout, The GARP Operator, The Activist Catalyst, and The Quality Rationalist all see a wide-moat cash machine at a PEG of 0.70 and a 6.4% FCF yield, with 28-36% upside to analyst consensus. The Asymmetric Bargainer joins at Bullish on the asymmetric payoff. The Intrinsic-Value Modeler is Neutral — his DCF says fair value is $81, so the fired trigger captured the move he would have waited for anyway. Only The Forensic Skeptic is Bearish, and he dissents on BUSINESS — earnings quality and a deteriorating balance sheet, not price — while even he concedes the FCF yield is attractive. The single Bearish voice on business quality keeps confidence LOW despite the +3 margin.

Key levels

Key levels · UBER

USD · as of 2026-08-22
Analyst consensus 101 ▲
R387
+10.4%
R282.14
+4.2%
R179.38
+0.7%
S176.53
−2.9%
S273.24
−7.1%
S370.63
−10.4%
NOW
78.8

Analyst consensus target 101 USD · range 70–150

Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.

Key resistance sits at $79.38 (weekly 61.8% Fibonacci retracement of the $101.99→$65.41 decline) — price closed just below it, and a breakout would confirm the corrective phase is over. R2 at $82.14–$82.62 is a confluence of monthly horizontal resistance and the monthly 23.6% Fibonacci; a weekly close above that band would signal Stage 2 resumption. Key support is the stacked $76.53–$76.83 zone (monthly EMA20 and weekly EMA50), a must-hold level for every bullish voice on the panel. Below that, $70.63–$71.20 is a high-volume accumulation zone (monthly 38.2% Fib plus monthly volume POC) where buyers have historically stepped in. The analyst consensus target of ~$101 sits ~28% above current price.

What legendary investors think

We ran Uber Technologies, Inc. past a panel of 6 legendary investors' frameworks.

The panel · 6 investors

🟢
4
Bullish
⚫
1
Neutral
🔴
1
Bearish
The GARP OperatorGrowth (GARP)🟢 BullishMed

Signal: A PEG of 0.70 on a wide-moat cash machine growing EPS at ~24% is the cheapest this name has been in years, and record first-time user acquisition over the past twelve months tells me the growth runway is not fading. Conviction: Conviction is held back because two of the last four quarters produced large negative earnings surprises, so the growth trajectory still has a volatility problem that needs another clean quarter to resolve.

The Intrinsic-Value ModelerValuation/DCF⚫ NeutralMed

Signal: My DCF lands at $81, putting the stock within 3% of fair value, which means the market has already priced in reasonable 15% revenue growth and a 15% terminal margin without leaving a margin of safety. Conviction: The narrow gap between price and intrinsic value suppresses conviction: there is simply no cushion if revenue growth decelerates even modestly below the 15% base case.

The Activist CatalystActivist/Capital Allocation🟢 BullishMed

Signal: A 6.4% FCF yield on a $10B+ free-cash-flow generator with 15% revenue growth is exactly the kind of simple, predictable compounder we commit capital to, and the Q3 guidance miss was noise on a $59B bookings line. Conviction: Conviction is strengthened by management's demonstrated capital-allocation discipline — resumed buybacks, prudent AV partnerships, a clean balance sheet — and by the fact that Pershing Square already holds 30 million shares confirming our thesis.

The Quality RationalistMental Models/Quality🟢 BullishMed

Signal: A capital-light tollbooth with 37% ROE, a wide network-effects moat, and an FCF yield north of 6% trading at 17x earnings is a wonderful business at a fair price, and the market's overreaction to a tiny guidance miss is the opportunity. Conviction: Confidence would be higher if insider ownership from the senior team were evident — management alignment is the one piece of the quality checklist I cannot verify.

The Forensic SkepticContrarian/Forensic🔴 BearishLow

Signal: Tangible book value per share has declined 12% in three months to $7.29 while net debt swung from near-zero to $4.74 billion in the red, and Q2's headline EPS beat was juiced by a $1.6 billion non-cash equity revaluation gain that masks underlying earnings. Conviction: Too many items on the balance sheet and income statement are moving in the wrong direction at once — shrinking tangible equity, ballooning net debt, and non-recurring gains propping up headline profitability — for me to trust the consensus growth narrative.

The Asymmetric BargainerContrarian/Deep Value🟢 BullishMed

Signal: A 17x earnings cash machine generating $10B+ in FCF with AV optionality priced at zero is a classic heads-I-win-tails-I-don't-lose-much setup — the Q3 guidance miss was a 0.1% bookings haircut that triggered a 5% selloff, exactly the overreaction Dhandjo investors exploit. Conviction: The expected-value math is compelling because the base case alone delivers 35% upside to $106, and the downside floor near $67 is cushioned by real free cash flow generation, not speculative hope.

Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.

Where they agree — and where they clash

Common ground

  • Every voice agrees Uber's core mobility-and-delivery platform possesses a genuine wide moat built on network effects, driver liquidity, and global scale across 70+ countries.
  • Five of six voices acknowledge the $10B+ trailing free cash flow as a real and durable cash-generation engine, not an accounting artifact (The Forensic Skeptic concedes the FCF yield is attractive even while questioning earnings quality).
  • The panel is unanimous that the Q3 guidance miss was quantitatively trivial — a 0.1–3% delta on a $59B bookings base — and that the selloff it triggered was disproportionate.
  • All bullish voices and the Neutral voice cite $76.53 (the monthly EMA20) as the structural invalidation level; a weekly close below that would break the Stage 2 uptrend that underpins every constructive thesis.

The real debate

  • The Quality Rationalist and The Activist Catalyst see a capital-light compounder whose 37% ROE and wide moat justify a growth premium at 17x earnings, while The Forensic Skeptic sees a business consuming its own tangible equity — book value per share has fallen 12% in one quarter — and argues that normalized earnings are closer to $2.80 than the $3.53 consensus, making the PEG of 0.70 a distortion.
  • The Intrinsic-Value Modeler's DCF lands at $81, implying the stock is already fairly priced with no margin of safety, while The Asymmetric Bargainer and The Activist Catalyst see a clear 28–36% runway to analyst consensus at $101–107.
  • The GARP Operator treats the Q3 guidance miss as a one-off volatility event in an otherwise intact 24% EPS growth story, whereas The Forensic Skeptic treats it as a symptom of a balance sheet under strain — $6.8B in cash consumed and $2.4B in new debt added over six months is not, in his framework, the profile of a company compounding conservatively.

The question it comes down to: Does the cash flowing out of Uber's balance sheet — $6.8 billion in six months — represent an investment cycle that will widen the moat and accelerate returns, or is it early evidence that the business model is consuming capital faster than the headline free-cash-flow figures imply?

The bottom line

  • Trigger to confirm the breakout: A weekly close above $82.14 (R2, monthly horizontal with Fibonacci confluence) would confirm Stage 2 resumption and elevate panel confidence from LOW to MEDIUM without changing the BUY verdict.
  • Risk to monitor: A weekly close below $76.53 (monthly EMA20) breaks the Stage 2 structure every bullish voice cites as invalidation and would flip the verdict to SELL, signaling the bounce was a trap.
  • Next catalyst: Q3 2026 earnings in late October must deliver clean GAAP net income — free of non-cash revaluation gains — and bookings in line with the $59B guide to restore earnings-quality credibility and potentially flip The Forensic Skeptic.
  • Further out: Tangible book value per share stabilizing or reversing its decline in the next two quarterly filings would neutralize the Bearish case's strongest factual pillar.

contact@verdixhq.com · Published 2026-08-22 · Prices as of 2026-08-22 · Time horizon: 3–12 months · Founder holds a direct position in UBER · UBER verdict history → · Methodology →

Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.

Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.

Stay ahead of UBER's next verdict

The panel's view can flip on new earnings, a guidance cut, or a valuation shift. Get the update the moment it happens — not weeks later.

One email, only on a verdict change. Unsubscribe anytime.